Frontiers 2023

St Mark’s 21st Annual International Congress, Frontiers in Colorectal and Gastrointestinal Disease  

It is my pleasure and privilege as Dean of St Mark’s Academic Institute to welcome you to London to our 21st Annual Frontiers in Colorectal and Intestinal Disease. This year the spotlight is on colorectal cancer. We look forward to welcoming a face-to-face audience to the magnificent Glaziers Hall, 9 Montague Place, London Bridge, London, SE1 9DD.

In addition, we are delighted to welcome our online audience from around the world. We will be making full use of high quality audio visual facilities to give our audience an excellent experience, whether you are with us in person, or joining us from elsewhere in the world.

The Congress will cover a broad range of topics, all of which are multidisciplinary, and encompass real issues that we deal with day-to-day in our clinics, presented by leading experts.

We will also present cutting edge research, and are honoured to have James East (UK) as our Sir Francis Avery Jones Visiting Professor, Eloy Espín Basany (Spain) as our Sir Alan Parks Visiting Professor, Rodrigo Perez (Brazil) delivering the Professor John Lennard-Jones State of the Art Lecture and Andrea Cercek (USA), who will be delivering the Basil Morson State of the Art Lecture.

We will combine medical, endoscopic, radiological, oncological, surgical, nursing and nutritional expertise throughout the programme, and also ensure that our patients’ voice is loudly heard

The Congress is organised into a number of plenary sessions:

On Wednesday, we have sessions focusing on emergencies in colorectal cancer management, screening and diagnosis of colorectal neoplasia, endoscopic and surgical approaches to managing colorectal neoplasia, and the science of prehabilitation.

On Thursday, we will start with hearing the patients’ voice expressing their perspective on what is successful cancer treatment. This will be followed by how to best manage right-sided colorectal cancer, sessions on frontiers in colorectal cancer imaging, macro-management of colorectal cancer (is centralisation the solution?), cancer genetics and the role of immunotherapy.

Also on Thursday, we have a parallel meeting for inflammatory bowel disease, with sessions on ulcerative colitis, Crohn’s disease, and an afternoon dedicated to developing and delivering consistent models of care for monitoring patients, diet and IBD, and mental health issues in IBD patients.

On Friday, we will look at rectal cancer management, rare and complex cancers and the aftermath of colorectal cancer and its treatment.

We conclude our symposium with an interactive informal session with all the leading lights coming together for what should be an enlightening and entertaining discussion in ‘Have I got views for you’.

We would like to take this opportunity to express our gratitude to all sponsors for their support and contribution to this Congress.

We hope that you will find the next few days interesting, stimulating, educational and, at times, controversial.

We wish you an enjoyable time in London for the 21st Meeting of the Frontiers Congress.

This event is endorsed by ECCO